14Indexed trials
mesh condition
Plaque, Amyloid
Intelligence
Plaque, Amyloid intelligence: 14 indexed trials, 2 recruiting studies, 14 sponsors across 13 countries.
2Recruiting
14Sponsors
13Countries
Leading sponsors
AC Immune SA11 recruiting
Eli Lilly and Company10 recruiting
Emory University10 recruiting
I.R.A. Istituto Ricerche Applicate S.p.A.10 recruiting
Janssen Research & Development, LLC10 recruiting
Michael Rafii, MD, PhD11 recruiting
National Taiwan University Hospital10 recruiting
Novartis Pharmaceuticals10 recruiting
Sinotau Pharmaceutical Group10 recruiting
United Biomedical10 recruiting
University Hospital, Grenoble10 recruiting
University of Michigan10 recruiting
Geographic activity
United States7trials
United Kingdom3trials
Canada2trials
Taiwan2trials
Japan1trials
Belgium1trials
Puerto Rico1trials
Romania1trials
Spain1trials
Netherlands1trials
China1trials
France1trials
Leading interventions
ACI-24.060 at Dose A in Study Part 21trials
ACI-24.060 at Dose B in Study Part 1a1trials
ACI-24.060 at Dose B in Study Part 21trials
ACI-24.060 at Dose C in Study Part 1a1trials
ACI-24.060 at Dose C in Study Part 21trials
ACI-24.060 with an additional adjuvant at Dose D in Study Part 1b1trials
ACI-24.060 with an additional adjuvant at Dose E in Study Part 1b1trials
Apolipoprotein (ApoE) detection1trials
Baricitinib1trials
CNP5201trials
Candesartan1trials
ACI-24.060 at Dose A in Study Part 1a1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.